Researchers Want To Use mRNA Technology For “Every Imaginable Infectious Disease”

Despite the unprecedented disaster of the mRNA COVID-19 jabs, there’s still a massive pipeline of injections utilizing the dangerous technology.

Penn Medicine’s Dr. Drew Weissman said researchers are trying to use mRNA technology to treat “every imaginable infectious disease.”

“At Penn, our researchers are using the mRNA platform to create vaccines for a wide variety of conditions,” Penn Medicine stated.

“Penn Medicine is home to the breakthrough messenger ribonucleic acid (mRNA) technology that enabled the highly successful COVID-19 vaccines from Moderna and Pfizer-BioNTech. Now the path is set for a whole new class of mRNA vaccines with the potential to eradicate countless other diseases, even cancer,” it added.

Weissman and Dr. Katalin Karikó were jointly awarded the 2023 Nobel Prize in Medicine for contributions to the mRNA technology for Pfizer and Moderna’s deadly injections.

According to LifeSiteNews, attorney Tom Renz warned that “all the childhood vaccines are going to be gene therapies” and mRNA technology will be integrated “into every vaccine out there.”

11 states have pursued bans on mRNA shots. Why? https://t.co/Gku7YvjG9j

— LifeSiteNews (@LifeSite) May 1, 2025

Per LifeSiteNews:

In addition, when presented with this prediction by Renz, Dr. Peter McCullough pointed LifeSiteNews to a pipeline of many mRNA so-called “vaccines” in development by Moderna. McCullough responded, “Yes, Moderna is one of many mRNA companies with an extensive portfolio of vaccines in development.”

The pharmaceutical company, which produced one of the most widely used mRNA COVID injections – and according to Open VAERS, the deadliest – is now working on a variety of mRNA “vaccines” for the flu, RSV, new variants of COVID, HIV, EBV, Lyme disease, Monkeypox, and many other viruses and diseases, including cancer.

PennMedicine has also listed a wide range of diseases for which mRNA injections are being studied or developed, including “all coronaviruses,” avian bird flu, malaria, genetic diseases, heart attacks, and neurodevelopmental disorders.

This is alarming considering the dangerous track record of mRNA injections. The U.S. federal government’s Vaccine Adverse Event Reporting System (VAERS), which historically has recorded only a small fraction of vaccine injuries, has as of March 28 reported 38,541 deaths from the COVID shots, higher by far than those reported for any other vaccines since 1990. A total of 1,662,426 adverse events from the COVID shots have also been reported to VAERS.

The Pfizer and Moderna COVID shots, which accounted for most injections, are distinguished from traditional vaccines by their mRNA technology, which did not come to market before the COVID outbreak largely due to safety concerns. In fact, as of May 2020, only one of Moderna’s mRNA candidates had passed Phase 1 trials, and StatNews had noted in 2016 that mRNA-based treatments are “highly risky,” and that “(b)ig pharma companies had tried similar work and abandoned it because it’s exceedingly hard to get RNA into cells without triggering nasty side effects.”

WATCH:

Congrats to #NobelPrize Laureates Dr. Katalin Karikó and Dr. Drew Weissman, awarded the 2023 @NobelPrize in Physiology or Medicine for their work which led to the development of the #mRNA COVID vaccines. @kkariko @WeissmanLab

Learn more: https://t.co/oXlxRHPrye pic.twitter.com/FTLrPevR7M

— Penn Medicine (@PennMedicine) October 2, 2023

From Penn Medicine:

Before COVID-19 erupted, a Penn-developed mRNA influenza (flu) vaccine was already in clinical trials. This existing work directly contributed to the speed at which drug makers could produce the mRNA COVID-19 vaccines.

With fast development and production times, mRNA vaccines are ideal for protection against new infectious diseases and variants of existing ones. Our researchers are at the forefront of mRNA vaccines for numerous infectious disease vaccines, including the following.

The list includes:

• Avian Bird Flu
• All Coronaviruses, such as SARS and MERS
• C. difficile
• Genital Herpes (HSV-2)
• Hepatitis C
• HIV
• Influenza
• Leptospirosis
• Malaria
• Norovirus
• Tuberculosis

Penn Medicine is also researching the use of mRNA technology for cancer, food and environmental allergies, genetic diseases, heart attacks, strokes, heart failure, and neurodevelopmental disorders.